计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
Moligand™ 级 提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存,充氩。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 9 篇同行评审文献引用。
Plumbagin, a quinoid constituent isolated from the root of the medicinal plant Plumbago zeylanica L, exerts anticancer and antiproliferative activities in animal models and in cell culture.
Plumbagin, a quinoid constituent isolated from the root of the medicinal plant Plumbago zeylanica L, exerts anticancer and antiproliferative activities in animal models and in cell culture.
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 萘 |
| 亚类(Subclass) | 萘醌 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 萘醌 |
| 其他上位类(Alternative Parents) | 醌类 芳基酮 1-羟基-4-未取代苯类化合物 1-羟基-2-未取代苯类化合物 乙烯基酸 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族同多环化合物 |
| 取代基(Substituents) | 1-羟基-2-未取代苯环化合物 - 1-羟基-4-未取代苯环化合物 - 芳香族同多环化合物 - 芳基溴化物 - 烃衍生物 - 酮 - 萘醌 - 有机氧化物 - 有机氧化合物 - 有机氧化合物 - 蒽醌 - 乙烯基羧酸 |
| 描述(Description) | 该化合物属于萘醌类有机化合物。这类化合物含有萘羟醌结构单元,其特征为苯环与苯并-1,4-二酮(醌)呈线性共轭。 |
| 外部描述符(External Descriptors) | a small molecule |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H301: 吞咽会中毒
H314: 造成严重的皮肤灼伤和眼睛损伤
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。
P264: 处理后要彻底洗手。
P270: 使用本产品时,请勿进食、饮水或吸烟。
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P321: 特殊处理(请参阅此标签上的...)。
P330: 漱口
P363: 再次使用之前,请清洗受污染的衣物。
P301+P330+P331: 如误吞咽:漱口。不要诱导呕吐。
P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。
P405: 密闭存放
P501: 将内容物/容器处理到。。。
P301+P316: 如果吞咽:立即寻求紧急医疗救助。
P305+P354+P338: 如果进入眼睛:立即用水冲洗几分钟。取下隐形眼镜(如果有的话),并且操作简单。继续冲洗。
P302+P361+P354: 如果接触皮肤:立即脱掉所有被污染的衣服。立即用水冲洗几分钟。
P316: 立即寻求紧急医疗救助。
| 1. Lijie Zhang, Dongxue Liang, Linlin Liu, Lihua Liu. (2023) Plumbagin alleviates obesity-related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway. Immunity Inflammation and Disease, 11 (9): (e1025). [PMID:37773696] [10.1002/iid3.1025] |
| 2. Wenzhe Xu, Yang Chen, Ruixu Yang, Yiying Fu, Wanxin Zhuang, Yonggang Wang, Yi Liu, Hao Zhang. (2023) “Reaction”-Like Shaping of Self-Delivery Supramolecular Nanodrugs in the Nanoprecipitation Process. ACS Nano, [PMID:37668306] [10.1021/acsnano.3c05229] |
| 3. Mengsi Zhang, Lu Wang, Hao Jin, Nan Zhao, Yi Liu, Shijie Lan, Shuwei Liu, Hao Zhang. (2023) Employing single valency polyphenol to prepare metal-phenolic network antitumor reagents through FeOOH assistance. JOURNAL OF CONTROLLED RELEASE, [PMID:37196899] [10.1016/j.jconrel.2023.05.020] |
| 4. Yang Wang, Xin Sun, Yi Wang. (2022) Synthesis of pH-responsive covalent organic frameworks nanocarrier for plumbagin delivery. RSC Advances, 12 (25): (16046-16050). [PMID:35733662] [10.1039/D2RA03127B] |
| 5. Songtao Bie, Qiuyue Mo, Chen Shi, Hui Yuan, Chunshuang Li, Tong Wu, Wenlong Li, Heshui Yu. (2024) Interactions of plumbagin with five common antibiotics against Staphylococcus aureus in vitro. PLoS One, 19 (1): (e0297493). [PMID:38277418] [10.1371/journal.pone.0297493] |
| 6. Wang Kexin, Li Mingyang, Geng Yiming, Fu Xiao, Chen Zhanwei. (2025) Engineering of plumbagin-loaded zeolitic imidazolate frameworks for antibiofilm and infected wound healing. JOURNAL OF MATERIALS SCIENCE, [10.1007/s10853-025-11302-w] |
| 7. Chunshuang Li, Ming Lu, Ze Yao, Ruobing Liu, Ding Lu, Tenglong Ma, Xiang Li, Hui Shang, Songtao Bie. (2025) Functionalized carbon nanoparticles for plumbagin delivery: Physicochemical characterization, antibacterial activity, and molecular docking. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, [10.1016/j.jddst.2025.107551] |
| 8. Hui Yuan, Ming Lu, Chen Shi, Chunshuang Li, Ze Yao, Hui Shang, Xiang Li, Heshui Yu, Songtao Bie. (2025) Plumbagin disrupts the mature biofilm of Staphylococcus aureus. BIOFOULING, [PMID:41255249] [10.1080/08927014.2025.2589802] |
| 9. Jing-Jing Liu, Si-Dian Miao, Zhan-Yi Wang, Ya-Han Zhu, Bin-Bin Jiang, Shuang-Shuang Long, Shu-Qin Gao, Ying-Wu Lin. (2026) Inhibition of d-ribose-induced glycation of metalloprotein human myoglobin by bioactive quinones. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, [10.1016/j.saa.2026.127817] |